Form 4: Modular Medical Director DeSisto Boosts Stake

Modular Medical Director Duane M. DeSisto acquired 2,500 shares of common stock through the company's director compensation plan, increasing his direct beneficial ownership to 274,890 shares.

Summary

• Duane M. DeSisto, a Director of Modular Medical, Inc. (MODD), acquired 2,500 shares of the company's common stock.
• The transaction occurred on December 31, 2025.
• These shares were issued to Mr. DeSisto in accordance with Modular Medical's Outside Director Compensation Plan.
• Following this acquisition, Mr. DeSisto directly beneficially owns a total of 274,890 shares of Modular Medical common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it's a routine compensation, an increase in director ownership, even through a plan, generally signals continued alignment with company performance, which is a minor positive. There are no negative implications from this specific filing.

Positives

• The acquisition of shares by a director, even as part of a compensation plan, indicates continued alignment of management interests with shareholder interests.
• The transaction is a routine part of the company's established Outside Director Compensation Plan, reflecting stable corporate governance practices.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This routine insider transaction, part of a director compensation plan, does not provide specific insights into broader industry trends or competitive landscape. It primarily reflects internal corporate governance and compensation practices.

Comparison to Industry Standards

• Director compensation plans involving equity grants are a common practice across various industries, including medical technology, to align director incentives with long-term company performance.
• The specific number of shares granted would typically be benchmarked against peer companies' director compensation structures, though this filing does not provide sufficient detail for a direct comparison to specific companies or projects.

Stakeholder Impact

• Shareholders: The increase in director ownership, even through a compensation plan, can be viewed as a positive signal of continued alignment between the director's interests and shareholder value.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing details a routine acquisition of shares by a director as part of an established compensation plan. It does not represent a significant open-market purchase or sale that would typically signal a change in the company's fundamental outlook or warrant an immediate shift in investment recommendation. The transaction is an expected part of corporate governance and compensation, thus maintaining a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Modular Medical, MODD, insider transaction, director compensation, stock acquisition, beneficial ownership, Form 4